pre-update Archives

Publication

Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines

Optimal use and distribution of coronavirus disease 2019 (COVID-19) vaccines involves adjustments of dosing. Due…

CertaraJuly 31, 2021

On-Demand Webinar

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

This webinar was presented on June 30, 2021 by David R. Taft, Ph.D. Professor, Pharmaceutics,…

CertaraJuly 26, 2021

Video

What is BaseCase?

Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…

CertaraJuly 20, 2021

On-Demand Webinar

Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate

The paper “Opening a Debate on Open-Source Modelling Tools: Pouring Fuel on Fire vs. Extinguishing…

CertaraJuly 15, 2021

Blog

Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success

Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…

CertaraJuly 8, 2021

Video

Meet a Certara regulatory operations specialist

Meet Rachel Bombara, Sr. Regulatory Operations Specialist at Certara. In this brief video Rachel shares…

CertaraJuly 2, 2021

Blog

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…

CertaraJune 25, 2021

Press Coverage

Fundamentals of regulatory writing: the document development process

Regulatory writers lead the development of high-quality regulatory documents by working incollaboration with colleagues across…

CertaraJune 22, 2021

Blog

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

This blog post includes key takeaways from the opening session of Certara’s first Strategic Evidence…

CertaraJune 18, 2021

Blog

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Every FDA Advisory Committee meeting is unique, and the Cellular, Tissue, and Gene Therapies Advisory…

CertaraJune 15, 2021

pre-update

Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines

PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking

What is BaseCase?

Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate

Key Considerations to Ensure Maximal Probability of Antibody Drug Conjugate Development Success

Meet a Certara regulatory operations specialist

Maximizing Oligonucleotide Therapeutic Development: Pre-clinical and Translational Considerations

Fundamentals of regulatory writing: the document development process

Preparing for High Stakes Meetings; How to Best Convey a New Drug’s Value to Payers

Watershed Moment for the Future of Cell Therapy Development – FDA Advisory Committee Meeting

Newsletter sign up

Quick links

Solutions

Contact